Aspergilose pulmonar invasiva

Autores

  • Luís Andrade Interno do Internato Complementar do 5º ano de Medicina Interna
  • Luís Pedro Tavares Assistente Hospitalar Graduado de Medicina Interna
  • Paula Ferreira Assistente Hospitalar de Oncologia
  • José Luís Krug Assistente Hospitalar Graduado e Director do Serviço de Imagiologia

Palavras-chave:

aspergillus, aspergilose, voriconazol

Resumo

A aspergilose é causada por fungos do género Aspergillus,
que se encontram disseminados no meio ambiente. Apesar da
colonização dos seres humanos ser elevada, a doença devido à
invasão tecidular é incomum e ocorre principalmente na presença de imunossupressão.
Na maioria dos casos o prognóstico é mau, dadas as características epidemiológicas da população afectada e a patogenia
deste tipo de fungos. Desta forma, o diagnóstico e terapêuticas
precoces são essenciais para o controlo da infecção e têm repercussão no prognóstico.

Downloads

Não há dados estatísticos.

Referências

Kieren A Marr, Thomas Patterson, David Denning. Aspergillosis pathogenesis, clinical manifestations, and therapy. Infect Dis Clin N Am 2002; 16:875-894.

Andriole VT. Aspergillus infections: problems in diagnosis and treatment. Infect Agents Dis 1996 ;5(1):47-54.

Castagnola E, Bucci B, Montinaro E, Viscoli C. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol. Bone Marrow Transplant 1996 ;18 (Suppl 2):97-106.

Jantunen E, Anttila VJ, Ruutu T. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?. Bone Marrow Transplant 2002;30(12):925-929.

Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002 ;100(13):4358-4366.

Ohmagari N, Raad II, Hachem R, Kontoyiannis DP. Invasive aspergillosis in patients with solid tumors. Cancer 2004 ;101(10):2300-2302.

Graciete Freitas. Micoses subcutâneas e sistémicas. In: Wanda F. Canas Ferreira, João Carlos F. de Sousa. Microbiologia. Lidel. 2002; Vol 2: 329-343.

Segal, B. Mouldy oldy: how fungus lives among us. Blood 2005; 105:2239.

Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SL, St John LS, Komanduri KV. Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood 2005;105(6):2258-2265.

8. Rau WS. Aspergillus infections of the lung: radiological signs. Mycoses 1997;40 (2):25-32.

Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG, Stevens DA, Graybill JR. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000 ;79(4):250-260.

Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985 ;157(3):611-614.

Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 1986;81(2):249-254.

Horvath JA, Dummer. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996;100(2):171-178.

Wheat LJ. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 2003;5(4):158-166.

Walsh TJ, Shoham S, Petraitiene R. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004;42(10):4744-4748.

Forrest GN, Walsh TJ. Approaches to management of invasive fungal infections in patients with hematologic malignancies. Supportive Cancer Ther 2004; 2:21.

Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002 ;34(5):563-571.

Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347(6):408-415

Ficheiros Adicionais

Publicado

31-03-2009

Como Citar

1.
Andrade L, Tavares LP, Ferreira P, Krug JL. Aspergilose pulmonar invasiva. RPMI [Internet]. 31 de Março de 2009 [citado 19 de Junho de 2024];16(1):37-42. Disponível em: https://revista.spmi.pt/index.php/rpmi/article/view/1383

Edição

Secção

Casos Clínicos

Artigos mais lidos do(s) mesmo(s) autor(es)